Dr. Andre Goy & Dr. Andrew Pecora, J. Michael Armstrong & Tomas Gregorio

Dr. Andre Goy, Chairman and Director of the John Theurer Cancer Center and Andrew Pecora, VP of Cancer Services of the John Theurer Cancer Center at Hackensack University Medical Center talk about the cost of cancer treatment as well as innovations being made to treat the disease.

J. Michael Armstrong, CEO of Community Hope discusses the ways this non-profit is helping our Veterans with some serious issues they face including homelessness and metal health issues.

Tomas Gregorio, Senior Executive Director at NJIT's New Jersey Innovation Institute talks about the ways NJII is using a government grant to improve the quality and efficiency of healthcare in our state.

5/21/16
#2564

Dr. Andre Goy Highlights Research From the 2012 ASCO Meeting

Andre Goy, MD, MS, chief, Lymphoma Division, chairman, John Theurer Cancer Center at Hackensack University Medical Center, highlights some of the research that will be presented at the 2012 ASCO Annual Meeting, including news about novel small biological agents, antibody drug conjugates, and vaccines.

Dr. Andre Goy on Neoadjuvant Leuprolide and Abiraterone in High Risk Localized Prostate Cancer

Andre Goy, MD, MS, chief, Lymphoma Division, chairman, John Theurer Cancer Center at Hackensack University Medical Center, discusses a phase II trial that combined leuprolide acetate with abiraterone acetate before prostatectomy in patients with localized high-risk prostate cancer.

Read more at

Regional Cancer Care Center’s Dr. Andre Goy on the Challenges of Treating Hodgkin’s Lymphoma

Dr. Andre Goy, from New Jersey’s best cancer center, Regional Cancer Care Associates ( on the challenges of treating Hodgkin’s Lymphoma. We have over 25 convenient locations in New Jersey and Maryland. Call us at (201) 510-0950. Video courtesy of OncLive.

Dr. Andre Goy at What's Next? How to get busy living!

Dr. Andre Goy, Chairman, Executive Director and Chief of Lymphoma at John Theurer Cancer Center, giving a presentation at Stupid Cancer NNJ What's Next? How to get busy living! young-adult cancer workshop, hosted at John Theurer Cancer Center.
Stacy Weathers, the Executive Director of the Leukemia & Lymphoma Society shares a few after Dr. Goy.

Dr. Andre Goy Discusses CAR-Modified T Cells in Lymphoma

Andre Goy, MD, MS, the Chief of the Division of Lymphoma at the John Theurer Cancer Center, discusses the apparent effectiveness of CD19-targeted chimeric antigen receptor (CAR)-modified T cells at treating patients with various types of lymphoma.

For more from the ASH meeting, visit

Dr. Andre Goy on Future Treatments for Patients With Diffuse Large B-Cell Lymphoma

Andre Goy, MD, MS, chief, John Theurer Cancer Center’s Division of Lymphoma, talks about the emerging novel therapies in diffuse large B-cell lymphoma (DLBCL).

For more resources and information regarding anticancer targeted therapies:

Prof John Gribben and Prof Andre Goy at ASH 2014: Treating mantle cell lymphoma (Part 2)

Prof John Gribben (Barts Cancer Institute, London, UK) interviews Prof Andre Goy (John Theurer Cancer Center, Hackensack, NJ) at the 2014 American Society of Hematology (ASH) Annual Meeting about novel therapies for mantle cell lymphoma (MCL). Topics include novel biologic therapies, such as lenalidomide-based and ibrutinib-based therapies; molecularly distinct MCL subtypes; and treatment of different age groups.

This programme has been supported by sponsorship from Celgene